Genus plc

Genus plc
Company typePublic
ISINGB0002074580 Edit this on Wikidata
IndustryBiotechnology
Founded1933
HeadquartersBasingstoke, Hampshire, UK
Key people
Iain Ferguson, Chairman[1]
Jorgen Kokke, CEO[1]
RevenueIncrease £689.7 million (2023)[2]
Decrease £40.5 million (2023)[2]
Decrease £31.8 million (2023)[2]
Websitewww.genusplc.com

Genus plc is a British-based business selling elite genetics and other products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.

History

The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.[5]

Operations

The company has three divisions:[6]

  • ABS - products for cattle
  • PIC - products for pigs
  • Genus R&D - management of the research and development pipeline for cattle, pigs and other species.

PIC's pedigree herds sire an estimated 30% of commercially reared pigs.[7]

References

  1. ^ a b "About Us - Our Team". Genus plc. Retrieved 2 August 2023.
  2. ^ a b c "Annual Report 2023" (PDF). Genus plc. Retrieved 12 February 2024.
  3. ^ The BSE Inquiry Archived 2008-10-10 at the Wayback Machine
  4. ^ "Genus agrees to acquire ABS Global". Milwaukee Business Journal. 3 August 1999. Retrieved 1 March 2020.
  5. ^ "Genus Completes Acquisition Of Sygen". The Pig Site. Archived from the original on 9 February 2012. Retrieved 28 March 2015.
  6. ^ "Genus". Market Watch. Retrieved 25 March 2018.
  7. ^ Devlin, Hannah (20 June 2018). "Scientists genetically engineer pigs immune to costly disease". The Guardian. Retrieved 11 December 2021.